D-0285-2024 Class II Terminated
FDA drug recall D-0285-2024 was initiated by Amerisource Health Services LLC on Jan 11, 2024 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specification. The recall status is terminated (terminated Sep 30, 2024). Affected quantity: 1,568 cartons.
Recall Details
- Product Type
- Drugs
- Report Date
- Feb 7, 2024
- Initiation Date
- Jan 11, 2024
- Termination Date
- Sep 30, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,568 cartons
Product Description
Rifampin Capsules USP, 150 mg, 30 Capsules (3 x 10) unit doses per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-575-21; NDC Unit Dose: 60687-575-11
Reason for Recall
Failed Impurities/Degradation Specification.
Distribution Pattern
Nationwide in the USA
Code Information
Lot #: 1008111, Exp. Date 01/31/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0285-2024
- openFDA file date
- Oct 26, 2026
- Loaded by RegDataLab
- Oct 27, 2026